Neil Chatterji
Stock Analyst at B. Riley Securities
(1.10)
# 3,624
Out of 4,876 analysts
19
Total ratings
23.53%
Success rate
-0.74%
Average return
Main Sectors:
Stocks Rated by Neil Chatterji
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLPT ClearPoint Neuro | Maintains: Buy | $20 → $28 | $11.80 | +137.29% | 4 | Apr 25, 2025 | |
| OPRX OptimizeRx | Maintains: Buy | $17 → $13 | $13.64 | -4.69% | 3 | Dec 24, 2024 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $95 → $50 | $40.93 | +22.16% | 2 | Nov 9, 2023 | |
| ARAY Accuray | Reiterates: Buy | $7.5 | $1.38 | +443.48% | 1 | Oct 4, 2023 | |
| ZUMZ Zumiez | Maintains: Neutral | $15 → $18 | $12.92 | +39.32% | 2 | Sep 8, 2023 | |
| KRMD KORU Medical Systems | Initiates: Buy | $4.5 | $3.63 | +23.97% | 1 | Sep 7, 2023 | |
| HYPR Hyperfine | Maintains: Buy | $2.5 → $3.5 | $0.74 | +371.95% | 3 | Aug 15, 2023 | |
| STXS Stereotaxis | Maintains: Buy | $6 → $5.5 | $2.29 | +140.17% | 2 | Mar 6, 2023 | |
| BFLY Butterfly Network | Initiates: Buy | $9.5 | $1.96 | +384.69% | 1 | Oct 4, 2022 |
ClearPoint Neuro
Apr 25, 2025
Maintains: Buy
Price Target: $20 → $28
Current: $11.80
Upside: +137.29%
OptimizeRx
Dec 24, 2024
Maintains: Buy
Price Target: $17 → $13
Current: $13.64
Upside: -4.69%
Establishment Labs Holdings
Nov 9, 2023
Maintains: Buy
Price Target: $95 → $50
Current: $40.93
Upside: +22.16%
Accuray
Oct 4, 2023
Reiterates: Buy
Price Target: $7.5
Current: $1.38
Upside: +443.48%
Zumiez
Sep 8, 2023
Maintains: Neutral
Price Target: $15 → $18
Current: $12.92
Upside: +39.32%
KORU Medical Systems
Sep 7, 2023
Initiates: Buy
Price Target: $4.5
Current: $3.63
Upside: +23.97%
Hyperfine
Aug 15, 2023
Maintains: Buy
Price Target: $2.5 → $3.5
Current: $0.74
Upside: +371.95%
Stereotaxis
Mar 6, 2023
Maintains: Buy
Price Target: $6 → $5.5
Current: $2.29
Upside: +140.17%
Butterfly Network
Oct 4, 2022
Initiates: Buy
Price Target: $9.5
Current: $1.96
Upside: +384.69%